IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: Correlations with eosinophil cationic protein, RANTES, IgE and disease severity

Archives of Dermatological Research

Volumn 290, Issue 1-2, 1998, Pages 25-27

  D'Auria, L ^a   Pietravalle, M ^a   Mastroianni, A ^a   Ferraro, C ^a   Mussi, A ^a   Bonifati, C ^a   Giacalone, B ^a   Ameglio, F ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

BF; BP; ECP; IgE; IL 5; RANTES; Serum

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 5; RANTES;

ADULT; AGED; ARTICLE; BLISTER; BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; EOSINOPHIL; HUMAN; PEMPHIGOID; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BLISTER; BLOOD PROTEINS; BODY FLUIDS; CASE-CONTROL STUDIES; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; INTERLEUKIN-5; LINEAR MODELS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PROTEINS; RANTES; RIBONUCLEASES;

EID: 0031906419     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050272     Document Type: Article

References (16)

1. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown A, Grant A (1993) RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 150:3442-3447
2. Ameglio F, D'Auria E, Bonifati C, Ferraro C, Mastroianni A, Giacalone B (1997) Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Br J Dermatol (in press)
3. Asbrink E, Hovmark A (1984) Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Acta Derm Venereol (Stockh) 64:243-246
4. Caproni M, Palleschi GM, Falcos D, D'Agata A, Cappelli G, Fabbri P (1995) Serum eosinophil cationic protein (ECP) in bullous pemphigoid. Int J Dermatol 34:177-180
5. Czech W, Krutmann J, Schopf E, Kapp A (1992) Serum eosinophil cationic protein is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 126:351-355
6. D'Auria E, Cordiali-Fei P, Pietravalle M, Ferraro C, Mastroianni A, Bonifati C, Giacalone B, Ameglio F (1997) The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corticosteroid therapy. Br J Dermatol 137:59-64
7. Endo H, Iwamoto I, Fujita M, Okamoto S, Yoshida S (1992) Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid. Arch Dermatol Res 284:312-314
8. Lever WF, Schaumburg-Lever G (1990) Non infectious vesicular and bullous diseases. In: Histopathology of the skin, 7th edn. Lippincott JB, Philadelphia, pp 125-130
9. Lopez AF, Sanderson CJ, Gamble J, Campbell HD, Young JG, Vadas MA (1988) Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 167:219-224
10. Nestor MS, Cochran AJ, Ahmed AR (1987) Mononuclear cell infiltrates in bullous disease. J Invest Dermatol 88:172-175
11. Pene J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy JY, De Vries JE (1988) Interleukin-5 enhances interleukin-4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol 18:929-935
12. Saurat JH (1990) In: Saurat JH, Laugier P, Grosshaus E, Lachapelle SM (eds) Maladies bulleuses. In: Dermatologie et venereologie, 2nd edn. Masson, Paris Milan Barcelona Dakota, pp 231-276
13. Schmidt E, Bastian B, Dummer R, Tony HP, Brocker EB, Zillikens D (1996) Detection of elevated levels of IL-4, IL-6 and IL-10 in blister fluids of bullous pemphigoid. Arch Dermatol Res 288:353-357
14. Schweizer RC, Welmers BAC, Raaijmakers JAM, Zanen P, Lammers JW J, Koenderman L (1994) RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83:3697-3704
15. Snedcor GW, Cochran WG (1967) Statistical methods, 6th edn. Iowa State University Press, Ames
16. Tsuda S, Miyasato M, Kasada M et al (1988) Eosinophil-mediated basement membrane zone injury in bullous pemphigoid. J Invest Dermatol 90:614